Printer Friendly

Boom in Europe seen.

LONDON -- The market for generic drugs in Europe is expected to rise sharply over the next six years, as an aging population and increasing health care costs drive demand for less-expensive medicines and the expiration of patented drugs opens the way for generic equivalents.

In a report released in July the consulting firm Frost & Sullivan Inc. forecasts that the European generic drug market will reach $35.9 billion in 2013, nearly double the $17.18 billion spent by Europeans on generics last year.

The report points out that the major challenge facing several countries in Europe is to establish a sustainable health care model in which generics can provide savings to payers and innovative drugs can provide a fair rate of return to manufacturers.

The European generics market is highly competitive, which has added pressure on the pharmaceutical industry to develop new and innovative drugs.

So far the cost savings that have resulted from generics have enabled governments to reimburse pharmaceutical companies on those development costs, the study says.

Pricing and reimbursement, because they have a direct bearing on health care costs, are critical to the generics market.

The report points out that European countries that offer incentives to pharmacists and physicians to prescribe generic medications would have a large impact on the market.

The European markets for generic drugs broadly fall into two categories: such free markets as the United Kingdom and Germany, which are the two largest markets in Europe in terms of absolute value; and price-regulated markets, including France, Spain and Italy.

COPYRIGHT 2007 Racher Press, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RX RETAIL PHARMACY: Generic Drugs; overview on european drug market
Comment:Boom in Europe seen.(RX RETAIL PHARMACY: Generic Drugs)(overview on european drug market)
Publication:Chain Drug Review
Article Type:Report
Geographic Code:4E
Date:Aug 20, 2007
Words:255
Previous Article:GPhA aims to set record straight: the association contends that a TV report misstated some basic facts about generics.
Next Article:Policy conference slated for Sept.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters